Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Beate Wieseler

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Impetus Digital

- PMLiVE

Germany’s coronavirus infections climb but deaths remain low

Experts debate ‘anomaly’ as other countries record higher death rates

- PMLiVE

Policy and public health: all the decisions we can’t see

January was a bad month for healthcare in China

german flag

German pharma experiencing a ‘Brexit boost’

Opinion poll ranked Germany as top pharma market in EU

- PMLiVE

Amgen gets block on sales of Repatha rival in Germany

Part of ongoing battle with Sanofi and Regeneron

- PMLiVE

In conversation with Pfizer’s Erik Nordkamp

Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe

- PMLiVE

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance

- PMLiVE

Transparency and accountability: tackling opacity and blame head-on

Let’s be honest, big pharma lacks trust and many love to hate it. Faceless corporations tainted by past own-goals, profiteering, cherry-picked data and spun claims - so goes the lazy...

- PMLiVE

Is trust in healthcare improving?

Edelman’s Annual Trust Barometer for 2017 painted a sobering picture of trust around the globe with a collapse in trust in all four of the major institutions studied - business,...

- PMLiVE

AllTrials tracker site names clinical trial non-reporters

The FDAAA site seeks to highlight the failings of the FDA Amendments Act 2007

translational pharmacology medicine dose

Audit exposes gaps in pharma’s promises on trial transparency

Study group estimates nearly half of all clinical trials go unpublished

german flag

Germany’s pharma market set for stable growth

Annual growth of 4.9% expected over next four years

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links